Should the European Union lift the ban on snus?: Evidence from the Swedish experience

被引:80
作者
Fagerström, KO
Schildt, EB
机构
[1] Smokers Informat Ctr, Fagerstrom Consulting, S-25452 Helsingborg, Sweden
[2] Univ Hosp, Dept Oncol, Lund, Sweden
关键词
gateway; safety; smoke-free tobacco; smoking cessation; snus;
D O I
10.1046/j.1360-0443.2003.00442.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
The very low smoking prevalence in Sweden has received considerable attention. Sweden was the only country in Europe to reach the World Health Organizations' goal of less than 20%, daily smoking prevalence among adults by year 2000. Only 17% of Swedish men smoke. Some have argued that this has been achieved because Swedes use another form of tobacco instead. Sweden has a high level of use of a moist snuff product called 'snus'. Nineteen per cent of adult men and 1%, of women are daily users and the trend is increasing. Epidemiological studies have failed to find evidence that snus causes cancers, including oral cancer. Its adverse effects on the cardiovascular system are debated, but are certainly less than those of smoking. Recent studies among former smokers indicate that many men have quit smoking using snus. Forty-seven per cent of current snus users are former smokers and 28% of ex-smoking used snus at their last attempt to stop smoking. The association between high snus consumption and low smoking prevalence has been debated and challenged. It has been argued that snus may be a gateway to cigarette smoking. Recent data has found that among those starting tobacco use in the form of snus, 20% later go on to smoking while the same risk for those not starting with snus is 43%. On balance, there is reason to believe that having snus available to the Swedish population has been of benefit to public health. Repealing the ban on snus in the rest of the European Union might also have some positive effect, depending on the marketing.
引用
收藏
页码:1191 / 1195
页数:5
相关论文
共 37 条
[1]  
*AM CANC SOC, 2000, TOB CONTR COUNTR PRO
[2]  
[Anonymous], 1997, TOB HLTH GLOB STAT R
[3]   Smokeless tobacco use and atherosclerosis: An ultrasonographic investigation of carotid intima media thickness in healthy middle-aged men [J].
Bolinder, G ;
Noren, A ;
deFaire, U ;
Wahren, J .
ATHEROSCLEROSIS, 1997, 132 (01) :95-103
[4]   SMOKELESS TOBACCO USE AND INCREASED CARDIOVASCULAR MORTALITY AMONG SWEDISH CONSTRUCTION WORKERS [J].
BOLINDER, G ;
ALFREDSSON, L ;
ENGLUND, A ;
DEFAIRE, U .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1994, 84 (03) :399-404
[5]   USE OF SMOKELESS TOBACCO - BLOOD-PRESSURE ELEVATION AND OTHER HEALTH-HAZARDS FOUND IN A LARGE-SCALE POPULATION SURVEY [J].
BOLINDER, GM ;
AHLBORG, BO ;
LINDELL, JH .
JOURNAL OF INTERNAL MEDICINE, 1992, 232 (04) :327-334
[6]  
Bolinder Gunilla, 2002, Lakartidningen, V99, P3111
[7]   CARDIOVASCULAR RISK-FACTORS IN YOUNG SNUFF-USERS AND CIGARETTE SMOKERS [J].
ELIASSON, M ;
LUNDBLAD, D ;
HAGG, E .
JOURNAL OF INTERNAL MEDICINE, 1991, 230 (01) :17-22
[8]   RELATIONSHIP OF CIGARETTE-SMOKING AND SNUFF DIPPING TO PLASMA-FIBRINOGEN, FIBRINOLYTIC VARIABLES AND SERUM-INSULIN - THE NORTHERN SWEDEN MONICA STUDY [J].
ELIASSON, M ;
ASPLUND, K ;
EVRIN, PE ;
LUNDBLAD, D .
ATHEROSCLEROSIS, 1995, 113 (01) :41-53
[9]   MEASURING NICOTINE DEPENDENCE - A REVIEW OF THE FAGERSTROM TOLERANCE QUESTIONNAIRE [J].
FAGERSTROM, KO ;
SCHNEIDER, NG .
JOURNAL OF BEHAVIORAL MEDICINE, 1989, 12 (02) :159-182
[10]  
Fagerström KO, 1998, AM J MED, V104, P501